Li‐Xi Yang
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
-
- Cancer therapeutics and mechanisms 11
- DNA Repair Mechanisms 3
- Oncology 13
- Cancer-related Molecular Pathways 5
- Cancer Treatment and Pharmacology 4
- Co-authors
- Owen Chan (1 shared paper)Huynh Cao (4 shared papers)Evan B. Douple (3 shared papers)Huijuan Wang (2 shared papers)Huijuan Wang (5 shared papers)Russell W. Driver (2 shared papers)Xiandao Pan (2 shared papers)Tianyi Tang (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (3 papers)International Journal of Radiation Biology (2 papers)Mini-Reviews in Medicinal Chemistry (2 papers)Frontiers in Microbiology (1 paper)Cancer Immunology Immunotherapy (1 paper)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Li‐Xi Yang
36 papers receiving 1.9k citations
Li‐Xi Yang's Hit Papers
Peers
Comparison fields: 5 of 123
- Toxicology 80
- Oncology 430
- Cancer Research 217
- Molecular Biology 978
- Immunology 167
Countries citing papers authored by Li‐Xi Yang
This map shows the geographic impact of Li‐Xi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Xi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Xi Yang more than expected).
Fields of papers citing papers by Li‐Xi Yang
This network shows the impact of papers produced by Li‐Xi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Xi Yang. The network helps show where Li‐Xi Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Li‐Xi Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gamma-H2AX - a novel biomarker for DNA double-strand breaks. Hit paper breakdown → | 2008 | 1001 |
| 2 | Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. | 2002 | 127 |
| 3 | 2000 | 118 | |
| 4 | Improved chemotherapy for hepatocellular carcinoma. | 2012 | 103 |
| 5 | 2008 | 51 | |
| 6 | 1995 | 47 | |
| 7 | Recent developments in radiosensitization. | 2015 | 39 |
| 8 | New molecular mechanisms of action of camptothecin-type drugs. | 2006 | 37 |
| 9 | Current status in chemotherapy for advanced pancreatic adenocarcinoma. | 2013 | 37 |
| 10 | 2005 | 34 | |
| 11 | Current Status of Biological Therapies for the Treatment of Metastatic Melanoma. | 2016 | 31 |
| 12 | 2002 | 26 | |
| 13 | 1995 | 23 | |
| 14 | 2004 | 18 | |
| 15 | Centrosome impairments and consequent cytokinesis defects are possible mechanisms of taxane drugs. | 2005 | 18 |
| 16 | Enhancement of radiation-induced DNA damage and inhibition of its repair by a novel camptothecin analog. | 2010 | 18 |
| 17 | 2013 | 17 | |
| 18 | Novel chemoradiosensitizers for cancer therapy. | 2010 | 17 |
| 19 | Radiation-associated Cardiac Injury. | 2015 | 17 |
| 20 | Improved radiotherapy for primary and secondary liver cancer: stereotactic body radiation therapy. | 2012 | 16 |
About Li‐Xi Yang
Li‐Xi Yang is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Cancer Research and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (11 papers), Cancer-related Molecular Pathways (5 papers), Cancer Treatment and Pharmacology (4 papers), DNA Repair Mechanisms (3 papers), Microtubule and mitosis dynamics (3 papers), Carcinogens and Genotoxicity Assessment (3 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Synthesis and Biological Evaluation (3 papers). The work is most often cited by research in Toxicology (80 citations), Oncology (430 citations), Cancer Research (217 citations), Molecular Biology (978 citations) and Immunology (167 citations). Li‐Xi Yang has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Owen Chan, Huynh Cao, Evan B. Douple, Huijuan Wang, Huijuan Wang, Russell W. Driver, Xiandao Pan, Tianyi Tang, Caspian Oliai and Ge Huang. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, International Journal of Radiation Biology, Mini-Reviews in Medicinal Chemistry, Frontiers in Microbiology and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.